• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

药物研究——学术合作：业内人士视角

Pharmaceutical Research - Academic Collaborations: An Insider's Perspective.

作者信息

Djuric Stevan W

机构信息

Department of Pharmacology, School of Medicine, University of Virginia, Charlottesville, VA 22903, United States.

出版信息

ACS Med Chem Lett. 2025 Apr 11;16(5):851-855. doi: 10.1021/acsmedchemlett.5c00083. eCollection 2025 May 8.

DOI:10.1021/acsmedchemlett.5c00083
PMID:40365410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12067122/
Abstract

A constant pressure on the pharmaceutical industry is the need to develop new therapeutics in a more cost-effective and timely manner. In this letter, I describe the potential that the development and implementation of enabling chemistry technology has for reducing cycle time and cost of goods. Several of these innovations were produced through industry and academic collaborations in which complementary areas of expertise were brought to the table.

摘要

制药行业面临的持续压力是需要以更具成本效益和及时性的方式开发新疗法。在这封信中，我描述了使能化学技术的开发和实施在减少周期时间和商品成本方面的潜力。其中一些创新是通过行业与学术界的合作产生的，在这些合作中，互补的专业领域得以汇聚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/81b929375379/ml5c00083_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/c8cd6f3e28c4/ml5c00083_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/b4d1035ca741/ml5c00083_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/81b929375379/ml5c00083_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/c8cd6f3e28c4/ml5c00083_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/b4d1035ca741/ml5c00083_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a752/12067122/81b929375379/ml5c00083_0004.jpg

相似文献

1
Pharmaceutical Research - Academic Collaborations: An Insider's Perspective.药物研究——学术合作：业内人士视角
ACS Med Chem Lett. 2025 Apr 11;16(5):851-855. doi: 10.1021/acsmedchemlett.5c00083. eCollection 2025 May 8.
2
Perspectives on outcome: what disability insiders and outsiders each bring to the assessment table.结果视角：残疾群体内部人士和外部人士在评估中各自带来的因素。
Arch Phys Med Rehabil. 2009 Nov;90(11 Suppl):S36-40. doi: 10.1016/j.apmr.2009.04.024.
3
Participation: the insider's perspective.参与：内部人士的观点。
Arch Phys Med Rehabil. 2010 Sep;91(9 Suppl):S34-7. doi: 10.1016/j.apmr.2009.11.030.
4
An insider's guide to knowledge transfer. From Academia to industry.知识转移的业内指南：从学术界到产业界
Med Device Technol. 1999 May;10(4):34-6.
5
Carol Everett on an insider's perspective of the abortion industry. Interview by Andrew Alatis.卡罗尔·埃弗雷特谈堕胎行业的内幕视角。安德鲁·阿拉蒂斯采访。
Health Matrix. 1989 Summer;7(2):62-8.
6
Human experience in disablement: the imperative of the ICIDH.人类在残疾方面的经历：《国际功能、残疾和健康分类》的必要性。
Disabil Rehabil. 1995 Apr-Jun;17(3-4):135-44. doi: 10.3109/09638289509166708.
7
Vulnerable persons in society: an insider's perspective.社会中的弱势群体：一个圈内人的视角。
Int J Qual Stud Health Well-being. 2021 Dec;16(1):1863598. doi: 10.1080/17482631.2020.1863598.
8
Solutions to expand microbiome sciences in the Caribbean Region: an insider's perspective.扩大加勒比地区微生物组科学的解决方案：内部人士视角
Trends Microbiol. 2025 May;33(5):475-478. doi: 10.1016/j.tim.2024.12.005. Epub 2025 Jan 8.
9
A third seat at the table: an insider's perspective on patient representatives.会议桌旁的第三个席位：患者代表的内部视角
Hastings Cent Rep. 2011 Jan-Feb;41(1):29-31. doi: 10.1002/j.1552-146x.2011.tb00097.x.
10
1987: An insider's perspective on the retirement industry. Part 1.
Contemp Longterm Care. 1987 Dec;10(12):48-9.

本文引用的文献

1
High-Throughput Reaction Screening with Nanomoles of Solid Reagents Coated on Glass Beads.高通量反应筛选：使用涂覆在玻璃珠上的纳摩尔固体试剂。
Angew Chem Int Ed Engl. 2019 Jun 11;58(24):7987-7991. doi: 10.1002/anie.201900536. Epub 2019 May 7.
2
Electrochemical Aminoxyl-Mediated α-Cyanation of Secondary Piperidines for Pharmaceutical Building Block Diversification.电化学氨氧基介导的仲哌啶α-氰化反应用于药物砌块的多样化构建。
J Am Chem Soc. 2018 Sep 12;140(36):11227-11231. doi: 10.1021/jacs.8b08145. Epub 2018 Aug 31.
3
Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule Libraries.
小分子文库快速合成-纯化-测试集成平台
ACS Med Chem Lett. 2017 Mar 28;8(4):461-465. doi: 10.1021/acsmedchemlett.7b00054. eCollection 2017 Apr 13.
4
Synthesis of Fused Pyrimidinone and Quinolone Derivatives in an Automated High-Temperature and High-Pressure Flow Reactor.在自动化高温高压流动反应器中合成融合的嘧啶酮和喹诺酮衍生物。
J Org Chem. 2017 Jan 20;82(2):1073-1084. doi: 10.1021/acs.joc.6b02520. Epub 2017 Jan 10.
5
How to improve R&D productivity: the pharmaceutical industry's grand challenge.如何提高研发生产力：制药行业的重大挑战。
Nat Rev Drug Discov. 2010 Mar;9(3):203-14. doi: 10.1038/nrd3078. Epub 2010 Feb 19.
6
Concise construction of novel bridged bicyclic lactams by sequenced Ugi/RCM/Heck reactions.通过顺序进行的乌吉反应/关环复分解反应/赫克反应简洁构建新型桥连双环内酰胺
Org Lett. 2007 Nov 22;9(24):5119-22. doi: 10.1021/ol7023373. Epub 2007 Nov 1.
7
Synthesis of novel and uniquely shaped 3-azabicyclo[4.2.0]octan-4-one derivatives by sequential Ugi/[2+2] ene-enone photocycloadditions.
Org Lett. 2007 Mar 29;9(7):1299-302. doi: 10.1021/ol070164l. Epub 2007 Feb 27.